Medical Licensing (MD/DO) · Independent exam preparation
ABIM Internal Medicine Certification Examination Study Guide
Practise diagnostic reasoning, test interpretation and treatment decisions across internal medicine through 60 focused concepts, 20 questions and 20 recall cards.
By CertMedbry · Updated 18 October 2026
Practise choosing informative tests, recognizing urgent presentations, interpreting conflicting results and selecting treatments that change outcomes. This selective guide develops 60 clinical decisions across all 18 domains of the ABIM Internal Medicine Certification Examination. The [official January 2026 certification blueprint](https://www.abim.org/media/wvwoy3wi/internal-medicine-cert.pdf) defines the full examination scope; its many additional topics require further study. Original questions and recall cards support learning without predicting examination performance.
Try 20 free practice questionsWhat is the exam format?
Check the question types, timing and outline before planning your revision.
Which certification examination does this guide address?
The ABIM Internal Medicine Certification Examination, awarded by the American Board of Internal Medicine. Passing the examination is one component of certification alongside education, postgraduate training, clinical competence, licensure and procedural requirements. Medical licensure is a separate prerequisite; this examination concerns initial internal medicine specialty board certification.
How many questions are there, and which questions count toward the score?
The January 2026 blueprint specifies up to 240 single-best-answer multiple-choice questions, including approximately 35 new questions that do not count toward the score. These qualified figures do not establish an exact guaranteed scored-question count.
Internal Medicine Blueprint—Certification Examination (CERT)
What question styles and clinical materials can appear?
Most questions present patient scenarios requiring diagnosis, test selection or interpretation, treatment decisions, risk assessment, epidemiologic reasoning or clinically relevant pathophysiology. Materials may include photographs, radiographs, electrocardiograms and heart or lung sound recordings. The 20 questions here are independently authored four-option learning drills, rather than official examination items.
Internal Medicine Blueprint—Certification Examination (CERT)
Where should appointment duration, delivery and break arrangements be checked?
Use ABIM's current examination appointment and scheduling instructions for duration, break allocation, testing location and delivery arrangements. The cited certification blueprint establishes clinical scope and question format but does not specify these appointment details or establish computer-adaptive operation.
Internal Medicine Blueprint—Certification Examination (CERT)
Which blueprint version applies, and what changes are scheduled?
This guide follows the currently linked certification blueprint bearing a January 2026 footer date. No separate effective date is stated. ABIM schedules publication of the expanded internal medicine blueprint for January 2027 and implementation for certification examinations in fall 2027. Check the outline applicable to your examination date.
Blueprints · Internal Medicine Blueprint—Certification Examination (CERT) · Expanded Blueprints
How should the official domain percentages guide preparation?
Approximate weights are Cardiovascular Disease 14%; Endocrinology, Diabetes, and Metabolism, Gastroenterology, Infectious Disease, Pulmonary Disease, and Rheumatology and Orthopedics 9% each; Hematology, Nephrology and Urology, and Medical Oncology 6% each; Neurology and Psychiatry 4% each; Dermatology, Obstetrics and Gynecology, and Geriatric Syndromes 3% each; Allergy and Immunology and Miscellaneous 2% each; Ophthalmology and Otolaryngology and Dental Medicine 1% each. Actual examinations may vary. Hypertension's cross-listed 5% allocation is already included in the total. This selective learning set does not reproduce every official percentage.
Internal Medicine Blueprint—Certification Examination (CERT)
Does the certification blueprint also describe maintenance assessments?
ABIM lists certification and maintenance assessment blueprints separately. This guide uses the initial certification blueprint. Maintenance assessments, longitudinal assessment arrangements and subspecialty certification examinations have separate requirements and outlines.
These independently authored learning materials emphasize the relationship between clinical findings, disease mechanisms and management decisions. Each concept connects a substantive principle with its application and a common reasoning error.
Outline used: Internal Medicine Blueprint—Certification Examination (CERT), January 2026 footer date; current certification blueprint linked by ABIM and opened on 2026-10-09. No separate effective date is stated in the PDF. The workbook label 'American Board of Internal Medicine (ABIM) Certification Examination' maps to the officially named ABIM Internal Medicine Certification Examination; the assigned canonical slug is preserved. This mapping concerns initial internal medicine board certification.
60 key concepts: understand, apply and avoid the traps
Work through the questions by exam domain. Explain the answer in your own words, try the example, then check the common pitfall.
Allergy and Immunology2%
9.When should epinephrine be given for anaphylaxis?
Anaphylaxis is a rapidly evolving systemic hypersensitivity reaction that can compromise airway, breathing or circulation. Intramuscular epinephrine is the first-line treatment because it counteracts vasodilation, edema and bronchoconstriction. A reaction with acute respiratory compromise or hypotension after a likely allergen can warrant treatment even without hives. Antihistamines address selected cutaneous symptoms but cannot substitute for epinephrine. Treatment should not wait for laboratory confirmation or progression to complete cardiovascular collapse.
Apply it
Minutes after a food exposure, a patient develops wheezing, throat tightness and lightheadedness. Give intramuscular epinephrine promptly while arranging emergency support; do not wait for an antihistamine to improve the respiratory or circulatory findings.
Common pitfall: Requiring urticaria or shock before treatment misses anaphylaxis presentations in which dangerous respiratory or circulatory involvement precedes or occurs without prominent skin symptoms.
10.How does C1 inhibitor–related hereditary angioedema differ from histaminergic swelling?
C1 inhibitor deficiency or dysfunction permits excessive bradykinin generation, increasing vascular permeability. Recurrent swelling without urticaria, abdominal attacks and a compatible family history suggest this mechanism; C4 and C1 inhibitor antigenic and functional testing support diagnosis. On-demand treatments target the pathway: C1 inhibitor replacement restores inhibition, icatibant blocks bradykinin B2 receptors, and ecallantide inhibits plasma kallikrein. Suspected laryngeal involvement requires immediate airway assessment and targeted treatment. Antihistamines do not reliably control bradykinin-mediated attacks, so an emergency plan must identify effective attack treatment.
Apply it
A patient with established hereditary angioedema develops tongue swelling and voice change without hives. Arrange immediate airway assessment and administer available targeted on-demand treatment rather than waiting for an antihistamine response.
Common pitfall: Absence of hives identifies a possible mechanism, not a benign attack. Targeted medication must accompany urgent airway assessment when laryngeal swelling is suspected.
Cardiovascular Disease14%
1.Why do mechanical prosthetic valves require vitamin K antagonist anticoagulation?
Mechanical valve surfaces promote thrombus formation, creating risks of prosthetic obstruction and systemic embolism. Vitamin K antagonist anticoagulation remains the recommended oral strategy; direct oral anticoagulants are contraindicated for mechanical prostheses. The target INR depends on valve position, prosthesis characteristics and thromboembolic risk factors. Distinguish a mechanical valve from a bioprosthesis before selecting therapy, because their antithrombotic requirements differ substantially and cannot be inferred merely from the phrase valve replacement.
Apply it
A patient with a mechanical mitral valve requests apixaban because INR testing is inconvenient. Explain that the valve type determines anticoagulant suitability, continue a vitamin K antagonist and address monitoring barriers directly.
Common pitfall: Applying atrial fibrillation prescribing habits to a mechanical valve overlooks a separate thrombogenic device indication; convenience does not establish direct oral anticoagulant safety.
2020 ACC/AHA Heart Valve Disease Guideline: Key Perspectives, Part 3
2.How should blood pressure targets be interpreted in chronic kidney disease?
KDIGO suggests a systolic blood pressure target below 120 mm Hg, when tolerated, for adults with high blood pressure and nondialysis, nontransplant CKD using standardized office measurement. Standardization matters because preparation, rest, positioning and measurement technique affect the result. The target cannot be transferred uncritically to casual readings. Frailty, symptomatic postural hypotension and limited life expectancy may justify less intensive treatment, making measurement quality and tolerability part of the decision.
Apply it
A patient with CKD has a hurried office systolic reading of 126 mm Hg and dizziness when standing. Repeat standardized measurements and assess orthostasis before intensifying medication solely to reach a numerical target.
Common pitfall: Treating every casual systolic reading above 120 as undertreatment ignores the measurement method and may expose a symptomatic patient to avoidable hypotension.
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
3.Which medication classes form foundational treatment for HFrEF?
Heart failure with reduced ejection fraction involves maladaptive neurohormonal activation and progressive ventricular dysfunction. Foundational therapy combines renin–angiotensin system inhibition, preferably an angiotensin receptor–neprilysin inhibitor when appropriate, an evidence-based beta blocker, a mineralocorticoid receptor antagonist and an SGLT2 inhibitor. These classes improve outcomes through complementary mechanisms. Loop diuretics relieve congestion but do not replace the disease-modifying regimen. Blood pressure, renal function, potassium and clinical stability guide initiation and adjustment.
Apply it
A stable patient with an ejection fraction of 30% takes a loop diuretic and feels less breathless. Review eligibility for all four foundational medication classes rather than treating symptomatic improvement as completion of therapy.
Common pitfall: Equating diuresis with comprehensive heart failure treatment confuses relief of fluid overload with therapies shown to reduce hospitalization and mortality over time.
4.Why should HFrEF therapy continue after ejection fraction improves?
Heart failure with improved ejection fraction describes a previous ejection fraction of 40% or less followed by improvement above 40%. Recovery of measured systolic function does not reliably mean the underlying susceptibility has disappeared. Withdrawal of therapy can allow recurrent ventricular dysfunction and heart failure. Guideline-directed treatment should therefore continue even when symptoms resolve. Distinguish improvement during effective treatment from proof that treatment is no longer necessary for maintaining that improvement.
Apply it
A patient whose ejection fraction rose from 25% to 55% asks to stop all heart failure medication. Recommend continuing disease-modifying therapy while reviewing adverse effects and adjusting individual agents when clinically necessary.
Common pitfall: A normal follow-up ejection fraction is an outcome of treatment, not a reliable test demonstrating permanent cure or freedom from future relapse risk.
5.What evidence supports a diagnosis of HFpEF?
Heart failure with preserved ejection fraction requires more than breathlessness and an ejection fraction of at least 50%. Symptoms or signs must be accompanied by evidence of increased filling pressures, either spontaneous or provoked. Natriuretic peptides, echocardiographic findings and, when necessary, hemodynamic assessment contribute to that evidence. Preserved systolic ejection does not exclude impaired ventricular relaxation or compliance. Conversely, preserved ejection fraction alone does not establish heart failure as the explanation for dyspnea.
Apply it
A patient has exertional dyspnea and an ejection fraction of 60%, but no established congestion. Assess filling-pressure evidence and competing pulmonary or hematologic explanations before assigning HFpEF as the cause of symptoms.
Common pitfall: Calling every breathless patient with a normal ejection fraction an HFpEF case bypasses the required physiological evidence and may obscure another treatable cause.
6.Which echocardiographic findings indicate severe high-gradient aortic stenosis?
Aortic stenosis creates fixed left ventricular outflow obstruction. Severe high-gradient disease is characterized by a peak aortic jet velocity of at least 4.0 m/s or a mean gradient of at least 40 mm Hg, with valve area typically 1.0 cm² or less. Flow and ventricular function affect these measurements, so discordant findings require integrated assessment. A small calculated valve area with a low gradient should not automatically be classified as ordinary high-gradient severe disease.
Apply it
An adult with exertional chest discomfort has a peak aortic velocity of 4.3 m/s and a mean gradient of 45 mm Hg. Recognize severe high-gradient stenosis and assess whether symptoms are attributable to it.
Common pitfall: Using valve area alone ignores flow-dependent gradients and measurement uncertainty; discordant low-gradient studies need a different assessment from concordant high-gradient severe stenosis.
2020 ACC/AHA Heart Valve Disease Guideline: Key Perspectives, Part 1
7.When does severe aortic stenosis warrant valve intervention?
Symptoms attributable to severe aortic stenosis or left ventricular systolic dysfunction are Class 1 indications for intervention. In asymptomatic patients at low surgical risk, intervention is reasonable under Class 2a guidance for decreasing exercise tolerance or an exercise-associated systolic pressure decrease of at least 10 mm Hg, peak aortic velocity at least 5.0 m/s, BNP above three times normal, or velocity progression at least 0.3 m/s annually. These findings justify consideration before spontaneous symptoms emerge. A valve team integrates anatomy, age, anticipated longevity and procedural risk when choosing replacement.
Apply it
An apparently asymptomatic patient with severe aortic stenosis has a peak velocity of 5.2 m/s and low surgical risk. Discuss intervention under the Class 2a criteria. A patient developing valve-related exertional presyncope instead has a symptomatic presentation requiring prompt evaluation under the Class 1 framework.
Common pitfall: Absence of resting symptoms does not exclude an intervention indication. Distinguish Class 1 symptomatic disease or systolic dysfunction from the conditional Class 2a findings in asymptomatic patients at low surgical risk.
2020 ACC/AHA Heart Valve Disease Guideline: Key Perspectives, Part 1
8.How should ECG and troponin findings guide evaluation of suspected acute coronary syndrome?
Obtain an ECG promptly when acute coronary syndrome is suspected. Persistent ischemic symptoms with diagnostic ST-segment elevation require an emergency reperfusion pathway; treatment should not await troponin results. An initially nondiagnostic ECG does not exclude evolving infarction, so recurrent symptoms warrant repeat ECG assessment. High-sensitivity cardiac troponin is the preferred biomarker for myocardial injury and must be interpreted within the clinical presentation and serial testing pathway. These principles are described in the [2025 ACC/AHA acute coronary syndromes guideline](https://www.ahajournals.org/doi/pdf/10.1161/CIR.0000000000001309).
Apply it
A patient with ongoing chest pressure develops diagnostic ST-segment elevation on a repeat ECG while the first troponin result remains pending. Activate emergency reperfusion evaluation immediately rather than waiting for biochemical confirmation.
Common pitfall: An early nondiagnostic ECG or pending troponin cannot justify delaying reperfusion when subsequent ECG findings establish STEMI. Repeat assessment matters when symptoms persist or recur.
Internal Medicine Blueprint—Certification Examination (CERT)
Dermatology3%
11.Which skin and nail findings favor plaque psoriasis?
Plaque psoriasis is an immune-mediated inflammatory disease that accelerates skin-cell turnover. Well-demarcated raised plaques with scale, commonly affecting the scalp, elbows, knees or lower back, support the diagnosis. Nail pitting, separation or other dystrophy can provide additional clues. Appearance varies with skin tone, so redness alone is an unreliable requirement. Distribution, plaque borders, scale and associated symptoms are more informative than assuming that every chronic itchy eruption represents eczema or fungal infection.
Apply it
A patient has persistent sharply bordered scaly plaques over both elbows and the scalp, with small pits in several fingernails. Integrate the distribution and nail findings when favoring psoriasis over an isolated superficial fungal eruption.
Common pitfall: Focusing only on lesion color can miss psoriasis in darker skin; scale, borders, anatomical pattern and nail changes often provide more consistent diagnostic information.
12.Why should joint symptoms change the assessment of psoriasis?
Psoriasis can be associated with inflammatory arthritis, so its consequences extend beyond visible skin disease. Persistent joint swelling, stiffness, pain or swelling of an entire digit should prompt assessment for psoriatic arthritis. Nail disease can reinforce suspicion but is not sufficient by itself. Recognizing the joint component matters because untreated inflammation can produce damage, and a treatment plan adequate for a few skin plaques may be inadequate for concurrent musculoskeletal disease.
Apply it
A patient using topical treatment for psoriasis develops prolonged morning stiffness and a swollen finger. Assess the joint complaint as possible inflammatory disease and arrange appropriate evaluation instead of merely escalating the skin cream.
Common pitfall: Attributing all joint pain to age or overuse can miss inflammatory arthritis; limited skin involvement does not reliably indicate limited disease elsewhere in the body.
Endocrinology, Diabetes, and Metabolism9%
13.How do cortisol and ACTH distinguish primary adrenal insufficiency?
Primary adrenal insufficiency reflects adrenal failure, so cortisol falls while pituitary ACTH rises through loss of negative feedback. In confirmed cortisol deficiency, an ACTH concentration more than twice the upper reference limit supports primary disease. Mineralocorticoid deficiency can cause volume depletion, hyperkalemia and increased renin. Hyperpigmentation also favors primary disease. Central adrenal insufficiency produces inadequate ACTH stimulation and usually preserves aldosterone, making potassium and pigmentation useful discriminators alongside appropriately timed biochemical testing.
Apply it
A patient has weight loss, orthostatic symptoms, hyperpigmentation, low morning cortisol and markedly elevated ACTH. Favor primary adrenal insufficiency and assess mineralocorticoid function rather than interpreting the cortisol result without its regulatory hormone.
Common pitfall: Low cortisol alone does not localize adrenal insufficiency; ACTH interpretation, clinical context and confirmatory testing distinguish adrenal failure from inadequate hypothalamic or pituitary stimulation.
14.What causes thyroid hormone excess in Graves disease?
Graves disease results from antibodies that stimulate the thyroid-stimulating hormone receptor, driving thyroid hormone synthesis and secretion despite suppressed pituitary TSH. A diffuse goiter, compatible eye disease or positive receptor antibodies supports this mechanism. This differs from destructive thyroiditis, in which stored hormone leaks from injured tissue rather than being newly synthesized in excess. The distinction affects treatment because blocking hormone synthesis addresses Graves hyperthyroidism but does not directly stop release of preformed hormone.
Apply it
A patient has weight loss, tremor, suppressed TSH, elevated thyroid hormones and positive TSH-receptor antibodies. Identify receptor stimulation as the mechanism and use it to distinguish Graves disease from transient destructive thyroiditis in planning treatment.
Common pitfall: Suppressed TSH establishes a regulatory response to hormone excess, not its cause; Graves disease and destructive thyroiditis can require different management despite similar initial thyroid tests.
15.Why can a normal-range PTH be abnormal during hypercalcemia?
High calcium should suppress parathyroid hormone secretion. A PTH concentration that is elevated or remains within the laboratory reference interval despite confirmed hypercalcemia is therefore physiologically inappropriate and suggests PTH-dependent disease. Primary hyperparathyroidism is a major explanation, but biochemical context and alternative causes still matter. Parathyroid imaging localizes abnormal glands for operative planning after diagnosis; it does not replace the calcium–PTH relationship as the basis of establishing the disorder.
Apply it
Repeated testing confirms hypercalcemia while PTH remains near the middle of its reference interval. Recognize inadequate suppression, investigate a PTH-dependent process and avoid dismissing primary hyperparathyroidism simply because the laboratory flags neither PTH result.
Common pitfall: A reference interval describes typical values, not the correct response to hypercalcemia; interpreting calcium and PTH independently can reverse the intended physiological conclusion.
16.Which laboratory results establish diabetes, and when is confirmation needed?
In nonpregnant adults, diabetes thresholds include A1C at least 6.5%, fasting plasma glucose at least 126 mg/dL, or two-hour plasma glucose at least 200 mg/dL during an oral glucose tolerance test. Random plasma glucose at least 200 mg/dL is diagnostic in a compatible symptomatic presentation. An asymptomatic abnormal screening result generally needs a second abnormal test for confirmation. Anemia and altered red-cell biology can make A1C misleading, favoring glucose-based assessment. These distinctions are explained in [NIDDK's diabetes testing guidance](https://www.niddk.nih.gov/health-information/diabetes/overview/tests-diagnosis).
Apply it
An asymptomatic adult has an A1C of 6.7% on routine screening. Arrange confirmatory testing. If substantial anemia makes A1C interpretation unreliable, use plasma glucose testing rather than assuming the A1C precisely reflects glycemia.
Common pitfall: A screening threshold does not eliminate the need for confirmation in an asymptomatic person. A1C and plasma glucose can disagree when red-cell factors distort the relationship between A1C and glycemia.
Internal Medicine Blueprint—Certification Examination (CERT)
17.When should suspected adrenal crisis be treated before confirmatory testing?
Adrenal crisis is acute cortisol deficiency with potentially life-threatening circulatory compromise, often triggered by illness or interruption of replacement treatment. Hypotension, volume depletion, gastrointestinal symptoms and compatible electrolyte abnormalities should raise suspicion. Immediate parenteral hydrocortisone and fluid resuscitation take priority over completing a stimulation test. Blood for cortisol and ACTH can be collected first if this causes no meaningful delay. The diagnostic workup can be completed after stabilization rather than withholding essential emergency treatment.
Apply it
A patient with known primary adrenal insufficiency develops vomiting and hypotension after missing replacement medication. Begin emergency glucocorticoid and fluid treatment immediately; obtain diagnostic samples only when doing so will not delay resuscitation.
Common pitfall: Waiting for a stimulation-test appointment or cortisol result in an unstable patient mistakes diagnostic completeness for clinical safety and can allow preventable deterioration.
Gastroenterology9%
18.Which initial tests best evaluate suspected celiac disease?
Tissue transglutaminase IgA is the preferred initial serologic test for most patients with suspected celiac disease. Total IgA helps identify deficiency that could make an IgA-based result falsely negative. Testing should occur while the patient consumes gluten, because dietary avoidance can reduce antibody levels and obscure the diagnosis. Positive serology commonly leads to duodenal biopsy in adults. The diagnostic sequence should establish disease before a lifelong gluten-free diet complicates subsequent interpretation and nutritional planning.
Apply it
An adult with chronic diarrhea and unexplained iron deficiency wants to begin avoiding gluten today. Arrange tissue transglutaminase IgA and assessment of total IgA while gluten remains in the diet, then interpret further testing accordingly.
Common pitfall: Symptom improvement after gluten avoidance is not specific for celiac disease, and starting the diet before testing can create falsely reassuring antibody or biopsy findings.
19.Which findings make gastrointestinal bleeding an emergency, and how can endoscopy help?
Vomiting blood or coffee-ground material, black tarry stool or visible rectal blood can indicate gastrointestinal hemorrhage. Dizziness, fainting, tachycardia, confusion and cold extremities raise concern for severe blood loss or shock and require emergency assessment. After initial assessment, endoscopy can identify a bleeding lesion and provide treatment through clips, bands, thermal methods or other hemostatic techniques. Presentation, severity and suspected location guide the procedure. See NIDDK's descriptions of [bleeding symptoms](https://www.niddk.nih.gov/health-information/digestive-diseases/gastrointestinal-bleeding/symptoms-causes/) and [treatment](https://www.niddk.nih.gov/health-information/digestive-diseases/gastrointestinal-bleeding/treatment).
Apply it
A patient taking an NSAID reports black tarry stools and near-syncope, with tachycardia and cool hands. Arrange emergency evaluation for significant gastrointestinal bleeding and subsequent localization and hemostasis rather than treating the presentation as uncomplicated dyspepsia.
Common pitfall: The amount of visible blood does not reliably describe physiological severity. Fainting, altered mentation and circulatory findings can identify dangerous bleeding even when the patient has not witnessed a large hemorrhage.
Internal Medicine Blueprint—Certification Examination (CERT)
20.Which ascitic fluid result requires treatment for spontaneous bacterial peritonitis?
An ascitic polymorphonuclear neutrophil count of at least 250 cells/mm³ supports spontaneous bacterial peritonitis and warrants prompt empiric treatment in the appropriate clinical setting. Culture negativity does not negate a qualifying neutrophil count. Fever and abdominal pain may be absent, particularly in decompensated cirrhosis. Ascitic fluid testing therefore changes management even when presentation is dominated by encephalopathy or renal deterioration. Evaluate for a secondary intra-abdominal source when the clinical or fluid pattern suggests one.
Apply it
A hospitalized patient with cirrhosis and new confusion has an ascitic neutrophil count of 340 cells/mm³ with cultures pending. Begin empiric treatment rather than waiting for culture growth or development of abdominal tenderness.
Common pitfall: A sterile culture does not exclude neutrocytic ascitic infection; delaying therapy until an organism grows substitutes a less sensitive finding for the actionable neutrophil threshold.
Why Timing Matters: Paracentesis on Admission for Cirrhosis with Ascites
21.How does the serum–ascites albumin gradient identify portal hypertensive ascites?
The serum–ascites albumin gradient is serum albumin minus ascitic fluid albumin, ideally measured from closely timed samples. A gradient of at least 1.1 g/dL supports portal hypertension as the mechanism of ascites. It does not identify cirrhosis uniquely, because other portal hypertensive states can also produce a high gradient. Ascitic total protein and the clinical context refine the differential. The gradient classifies the pressure-related mechanism rather than serving as an infection test.
Apply it
Serum albumin is 3.0 g/dL and ascitic albumin is 1.4 g/dL, producing a gradient of 1.6 g/dL. Recognize portal hypertension as likely, then use other findings to determine its underlying cause.
Common pitfall: Confusing a high albumin gradient with low ascitic protein can misclassify ascites; the gradient uses subtraction and answers a different question from total protein.
Why Timing Matters: Paracentesis on Admission for Cirrhosis with Ascites
22.Why should albumin accompany antibiotics for spontaneous bacterial peritonitis?
Spontaneous bacterial peritonitis can worsen circulatory dysfunction and precipitate kidney injury in cirrhosis. The 2021 AASLD practice guidance recommends intravenous albumin alongside antibiotics, using 1.5 g/kg on day 1 and 1 g/kg on day 3. Renal dysfunction or jaundice identifies patients more likely to benefit. Numerical thresholds used in historical risk-stratified studies should not become prerequisites for this recommendation. Albumin supports circulatory and renal protection; it neither replaces antimicrobial treatment nor serves merely to normalize the serum albumin concentration.
Apply it
A patient with confirmed spontaneous bacterial peritonitis has creatinine of 1.6 mg/dL. Start antibiotics with adjunctive albumin using the standard regimen, recognizing renal dysfunction as a predictor of greater benefit rather than the sole basis for treatment eligibility.
Common pitfall: Withholding albumin solely because historical high-risk thresholds are absent narrows the guidance incorrectly. Giving albumin without antibiotics leaves the ascitic infection untreated.
Hematology6%
23.What does a low ferritin establish in an anemic patient?
Ferritin reflects iron stores, and a clearly low concentration supports iron deficiency as a cause of anemia. Inflammation can increase ferritin, so a normal or elevated value does not always exclude deficiency. Hemoglobin and red-cell size characterize the anemia but cannot independently establish its cause. Interpret ferritin with the clinical context and other iron measurements when inflammation complicates assessment. Confirming deficiency should lead both to iron replacement and investigation of why iron became depleted.
Apply it
A patient with fatigue has anemia, small red cells and a ferritin clearly below the laboratory range. Identify depleted iron stores rather than attributing the anemia to chronic disease merely because another illness is present.
Common pitfall: Microcytosis is not specific for iron deficiency, while an inflammatory elevation in ferritin can conceal deficiency; neither finding should be interpreted without context.
24.When should a falling platelet count during heparin treatment prompt action for HIT?
Heparin-induced thrombocytopenia is an antibody-mediated, prothrombotic disorder. Assess clinical probability with the 4Ts: extent of platelet decline, timing, thrombosis and alternative causes. A decline exceeding 50% with new thrombosis after several days of heparin is particularly concerning. A high-probability presentation warrants stopping heparin and starting therapeutic-intensity non-heparin anticoagulation while testing proceeds. Immunoassays detect PF4–heparin antibodies; functional assays assess platelet activation. A reliably low 4Ts score generally argues against testing or empiric treatment. See the [ASH HIT pocket guide](https://www.hematology.org/-/media/hematology/files/education/clinicians/guidelines-quality/documents/ash_vte_hit_pocketguide.pdf).
Apply it
Seven days after starting heparin, a patient's platelets fall from 260 to 100 × 10⁹/L and a new DVT develops without another explanation. Treat this high-probability pattern by stopping heparin and starting a non-heparin anticoagulant while arranging confirmatory testing.
Common pitfall: The relative platelet decline matters even before the count becomes profoundly low. Thrombocytopenia in HIT signals substantial thrombotic risk, so simply withholding all anticoagulation can leave the mechanism untreated.
Internal Medicine Blueprint—Certification Examination (CERT)
25.Which neurologic findings make vitamin B12 deficiency especially important?
Vitamin B12 is necessary for normal blood-cell production and nervous-system function. Deficiency can cause numbness, tingling, gait difficulty and cognitive changes as well as megaloblastic anemia. Neurologic injury may occur without striking anemia and can become irreversible if treatment is delayed. A normal-looking hemoglobin result therefore does not exclude clinically important deficiency. Combining neurologic findings with dietary, gastrointestinal and medication history helps identify patients needing biochemical assessment and timely replacement.
Apply it
A patient with progressive foot numbness and impaired balance has only mild anemia. Include vitamin B12 deficiency in the evaluation rather than excluding it because the hematologic abnormality appears too small to explain the symptoms.
Common pitfall: Folate may improve the blood count without correcting B12-related neurologic injury; improvement in anemia alone does not demonstrate that the neurological mechanism has been treated.
26.How can vitamin B12 deficiency occur despite adequate dietary intake?
Dietary vitamin B12 must be released from food and absorbed through a process involving intrinsic factor and the intestine. Pernicious anemia disrupts intrinsic-factor availability through autoimmune gastric disease, making adequate intake insufficient protection. Gastric or intestinal surgery and other malabsorptive conditions can also interfere with absorption. Distinguishing inadequate intake from impaired absorption matters because replacement strategy and long-term needs differ. A diet containing animal products does not rule out deficiency when the absorptive pathway is impaired.
Apply it
An adult who regularly eats meat has low vitamin B12 after gastric surgery. Recognize impaired absorption as a plausible explanation and plan replacement around the underlying defect instead of offering dietary advice alone.
Common pitfall: Assuming that only strict dietary restriction causes B12 deficiency overlooks gastric and intestinal mechanisms; dietary adequacy and effective absorption are separate requirements for maintaining stores.
Infectious Disease9%
27.When should asymptomatic bacteriuria be left untreated?
Asymptomatic bacteriuria is bacterial growth in urine without symptoms attributable to urinary infection. In most nonpregnant adults, including many older adults and patients with diabetes, antibiotics do not improve relevant outcomes and can cause adverse effects or promote resistance. Pyuria alone does not convert colonization into symptomatic infection. The decision requires a symptom assessment rather than automatic treatment of a positive culture. New systemic instability still warrants evaluation for infection and other causes on its own merits.
Apply it
A nonpregnant adult with diabetes has a positive urine culture obtained during routine testing but no urinary symptoms, fever or instability. Avoid antibiotics and reconsider whether future screening cultures would provide a clinical benefit.
Common pitfall: A positive culture and pyuria can coexist with colonization; neither establishes symptomatic urinary infection or justifies antibiotics in an otherwise asymptomatic nonpregnant adult.
IDSA 2019 Clinical Practice Guideline Update for the Management of Asymptomatic Bacteriuria
28.Why is bacteriuria treated before selected endourologic procedures?
Endoscopic urologic procedures that cause mucosal trauma can introduce bacteria from the urinary tract into the bloodstream. Screening for and treating asymptomatic bacteriuria before such procedures reduces the risk of serious postoperative infection. The indication depends on expected mucosal injury, not simply the presence of any upcoming operation. Culture-directed treatment is preferred when possible. This exception should be distinguished from routine screening before elective nonurologic surgery, for which asymptomatic bacteriuria treatment is not recommended.
Apply it
A patient without urinary symptoms has bacteriuria before a planned endoscopic procedure expected to traumatize urinary mucosa. Arrange culture-directed perioperative treatment rather than applying the usual rule of leaving asymptomatic bacteriuria untreated.
Common pitfall: Extending this exception to every surgical procedure promotes unnecessary antibiotics; the relevant feature is urinary tract mucosal trauma, not surgery or instrumentation in general.
IDSA 2019 Clinical Practice Guideline Update for the Management of Asymptomatic Bacteriuria
29.How should possible active tuberculosis be evaluated after a positive infection test?
A positive interferon-gamma release assay or tuberculin skin test identifies immune sensitization to tuberculosis but does not distinguish latent infection from active disease. Symptoms, examination and chest imaging determine the need for microbiologic evaluation, including respiratory specimens when pulmonary disease is suspected. Smear microscopy, nucleic acid amplification and culture contribute different information. Symptomatic patients require evaluation for active disease before latent-infection treatment is selected, and a negative immune test cannot reliably exclude active tuberculosis.
Apply it
A patient with a positive interferon-gamma release assay also has cough, weight loss and night sweats. Obtain chest imaging and appropriate respiratory testing rather than immediately prescribing a latent-infection regimen without evaluating active disease.
Common pitfall: Treating the immune test as a disease-activity assay confuses evidence of infection with evidence of current infectious illness and can lead to inadequate treatment.
30.Which precautions are required for suspected infectious pulmonary tuberculosis?
Pulmonary or laryngeal tuberculosis can spread through airborne particles. Suspected infectious disease therefore calls for Airborne Precautions in addition to Standard Precautions while evaluation proceeds. Placement in an airborne infection isolation room and appropriate respiratory protection address this transmission route. A surgical mask on staff is not equivalent to a fit-tested respirator. Discontinuation depends on the diagnostic findings and applicable criteria, rather than a single immune test or early subjective improvement after treatment begins.
Apply it
A coughing inpatient has weight loss and imaging concerning for pulmonary tuberculosis. Initiate airborne isolation while collecting diagnostic specimens; do not wait for a positive culture before applying precautions appropriate to the suspected transmission route.
Common pitfall: Droplet precautions alone do not address airborne tuberculosis transmission; a pending diagnosis is not a reason to postpone isolation when infectious pulmonary disease is suspected.
Appendix A: Type and Duration of Precautions Recommended for Selected Infections and Conditions
31.Which precautions apply to disseminated herpes zoster?
Disseminated herpes zoster requires Airborne and Contact Precautions in addition to Standard Precautions until lesions are dry and crusted. The same heightened approach initially applies to localized zoster in an immunocompromised patient until dissemination is excluded. Localized disease in an immunocompetent patient has a different precaution profile when lesions can be covered. Host immune status and extent of lesions therefore determine infection-control decisions; the label shingles alone is insufficient to choose the appropriate measures.
Apply it
An immunocompromised inpatient develops vesicles across several body regions. Use airborne and contact isolation with standard measures, and maintain the required precautions until lesions are dry and crusted rather than relying only on covering the rash.
Common pitfall: Applying the localized immunocompetent zoster approach to disseminated disease understates transmission risk; both lesion distribution and immune status must be assessed before selecting precautions.
Appendix A: Type and Duration of Precautions Recommended for Selected Infections and Conditions
Miscellaneous2%
32.How is number needed to treat calculated from absolute risks?
For a beneficial treatment, absolute risk reduction equals control-event risk minus treatment-event risk. Number needed to treat is the reciprocal of that reduction expressed as a proportion, with the result rounded upward to a whole person. The estimate refers to a specified outcome and follow-up interval. Relative risk reduction cannot substitute for absolute risk reduction because baseline risk changes the expected absolute benefit. Uncertainty in the treatment effect also translates into uncertainty around the NNT.
Apply it
Over two years, an event occurs in 12% of controls and 8% of treated patients. The absolute reduction is 0.04, so the NNT is 25 for preventing one additional event over that interval.
Common pitfall: Using percentage points as whole numbers or taking the reciprocal of relative risk reduction produces an incorrect NNT and obscures how baseline risk affects benefit.
Nephrology and Urology6%
33.When does an abnormal kidney finding establish chronic kidney disease?
Chronic kidney disease requires abnormalities of kidney structure or function present for at least three months with implications for health. Reduced GFR below 60 mL/min/1.73 m² or qualifying markers of kidney damage can establish the diagnosis when chronicity is demonstrated. A single abnormal result may reflect acute kidney injury or transient variation. Prior measurements, persistent albuminuria, imaging or other evidence can establish duration. Repeat assessment and clinical context prevent acute abnormalities from being mislabeled as chronic disease.
Apply it
An outpatient has a first eGFR of 52 mL/min/1.73 m² during a dehydrating illness. Review earlier results and reassess after recovery rather than diagnosing CKD from that isolated measurement without evidence of chronicity.
Common pitfall: Waiting three months is not mandatory when prior evidence already proves chronicity, but one newly abnormal laboratory result alone should not automatically establish CKD.
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
34.How does CGA classification improve CKD risk assessment?
CKD classification incorporates Cause, GFR category and Albuminuria category, abbreviated CGA. GFR describes filtration, while albuminuria contributes independent prognostic information about kidney and cardiovascular outcomes. Patients with the same eGFR can have different risks when albumin excretion differs. Identifying the cause also directs disease-specific management. Classification should therefore preserve all three components rather than reducing CKD to a stage number derived only from creatinine or assuming that a stable eGFR means uniformly low risk.
Apply it
Two patients have an eGFR of 48 mL/min/1.73 m², but one has minimal albuminuria and the other has marked persistent albuminuria. Use both GFR and albuminuria to distinguish their prognostic profiles and management needs.
Common pitfall: An eGFR category alone is an incomplete risk summary; omitting albuminuria and cause can understate risk and conceal opportunities for disease-specific kidney protection.
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
35.Which changes establish acute kidney injury and require prompt causal assessment?
KDIGO defines acute kidney injury by any of three findings: serum creatinine increases at least 0.3 mg/dL within 48 hours; creatinine reaches at least 1.5 times baseline within the preceding seven days; or urine output falls below 0.5 mL/kg/hour for six hours. Assess perfusion, volume status, drug exposures and possible obstruction while monitoring creatinine and urine output. The change from baseline matters even when the absolute creatinine appears modest. See the [KDIGO acute kidney injury guideline](https://kdigo.org/wp-content/uploads/2016/10/KDIGO-2012-AKI-Guideline-English.pdf).
Apply it
During an acute illness, creatinine rises from 0.8 to 1.2 mg/dL in 36 hours. Recognize AKI from the 0.4 mg/dL increase and investigate reversible contributors rather than dismissing the result because the final value is near the laboratory reference range.
Common pitfall: A reference-range creatinine does not exclude an important acute decline from baseline. Creatinine and urine-output criteria are alternative routes to recognizing AKI; both need not be abnormal.
Internal Medicine Blueprint—Certification Examination (CERT)
36.How does postvoid residual measurement clarify urinary symptoms?
Postvoid residual measurement determines how much urine remains in the bladder after urination. Bladder ultrasonography or catheterization can demonstrate incomplete emptying in patients with hesitancy, weak stream, frequency or suspected overflow leakage. Symptoms alone do not establish retention, and a residual measurement does not identify its cause. Obstruction, impaired bladder contraction, medications and neurologic disease require further assessment. Acute painful inability to void demands prompt management rather than a routine outpatient testing sequence.
Apply it
An adult reports frequent small voids, weak stream and leakage without a clear sense of fullness. Measure the postvoid residual to assess incomplete emptying before assuming the leakage represents uncomplicated urgency-related incontinence.
Common pitfall: Frequent urination does not prove effective bladder emptying; treating presumed urgency without checking suspected retention can miss obstruction or impaired detrusor function causing overflow symptoms.
Neurology4%
37.Which movement pattern suggests Parkinson disease?
Parkinson disease is a progressive disorder associated with loss of dopamine-producing neurons and impaired movement control. Bradykinesia, rigidity and resting tremor are characteristic, often beginning more prominently on one side. Reduced arm swing, smaller handwriting and shuffling steps can reinforce the pattern. Diagnosis depends on the clinical presentation and assessment for alternatives rather than tremor alone. Medication-related parkinsonism and other neurologic disorders can resemble it, making progression, asymmetry and the full motor examination important discriminators.
Apply it
An older adult develops slowly progressive right-sided resting tremor, reduced right arm swing and difficulty initiating movement. Recognize a parkinsonian pattern and review medications and alternative causes rather than labeling the tremor from one feature alone.
Common pitfall: Not every tremor is Parkinson disease, and absence of a dramatic tremor does not exclude it; bradykinesia and the overall movement pattern carry diagnostic weight.
38.Why does fatigable weakness suggest myasthenia gravis?
Myasthenia gravis is an autoimmune disorder of neuromuscular transmission. Weakness typically worsens with repeated activity and improves with rest, often involving eyelids, extraocular muscles, swallowing or speech. The pattern reflects impaired transmission rather than loss of sensation, so numbness is not a defining feature. Antibody testing and electrophysiologic studies can support diagnosis. Bulbar or respiratory involvement changes urgency because worsening transmission can threaten airway protection or ventilation even when limb weakness appears modest.
Apply it
A patient develops evening diplopia and ptosis that improve after rest, with normal sensation. Evaluate neuromuscular transmission and ask specifically about swallowing and breathing rather than assuming the symptoms represent generalized fatigue.
Common pitfall: Describing fatigable focal weakness as nonspecific tiredness can delay diagnosis; respiratory and swallowing symptoms require particular attention even when ocular complaints dominate the presentation.
Obstetrics and Gynecology3%
39.Which contraceptive methods are appropriate when migraine includes aura?
Under the U.S. Medical Eligibility Criteria, combined hormonal contraception is category 4 for migraine with aura, indicating an unacceptable health risk. Estrogen-containing pills, patches and rings therefore share this restriction. The classification reflects concern about ischemic stroke risk and should not be bypassed merely because the patient is young. Progestin-only methods and intrauterine contraception have different classifications. Establish whether focal neurologic aura is present rather than grouping all migraine presentations together.
Apply it
A patient seeking contraception describes recurrent visual aura preceding headaches and requests a combined hormonal patch. Explain the estrogen-related restriction and discuss suitable progestin-only or intrauterine alternatives according to individual preferences and other conditions.
Common pitfall: Switching from an estrogen-containing pill to an estrogen-containing ring or patch does not remove the migraine-with-aura restriction; the relevant exposure is combined hormonal contraception.
40.Why is asymptomatic bacteriuria treated during pregnancy?
Pregnancy is an important exception to the usual avoidance of antibiotics for asymptomatic bacteriuria. Screening and treatment reduce maternal pyelonephritis risk, so absence of dysuria does not eliminate the indication. A urine culture establishes bacteriuria and guides selection of an appropriate pregnancy-compatible antibiotic. This preventive strategy should not be generalized to all asymptomatic adults. The decision arises from pregnancy-specific outcome evidence rather than from assuming every positive urine test represents an already symptomatic infection.
Apply it
A pregnant patient feels well but has significant bacteriuria on a screening culture. Arrange culture-directed treatment compatible with pregnancy rather than withholding therapy because the patient lacks urinary symptoms or previously required no treatment when nonpregnant.
Common pitfall: Applying the nonpregnant asymptomatic-bacteriuria rule during pregnancy misses a recognized benefit; pregnancy status changes the management decision even when the urine findings look similar.
IDSA 2019 Clinical Practice Guideline Update for the Management of Asymptomatic Bacteriuria
Medical Oncology6%
41.How can small cell lung cancer produce dilutional hyponatremia?
Small cell lung cancer can produce inappropriate antidiuretic hormone activity as a paraneoplastic syndrome. Retained water lowers serum sodium and osmolality while urine remains inappropriately concentrated. The patient may appear clinically euvolemic because this is principally a water-balance disorder. Diagnosis still requires exclusion of relevant alternatives, including adrenal insufficiency, thyroid dysfunction and medication effects. Recognizing the association helps connect an otherwise unexplained electrolyte pattern with lung malignancy without treating hyponatremia alone as proof of cancer.
Apply it
A patient with confirmed small cell lung cancer has hypotonic hyponatremia, concentrated urine and no obvious volume depletion. Consider inappropriate antidiuretic hormone activity while checking competing endocrine and medication explanations for the biochemical pattern.
Common pitfall: Hyponatremia is not specific for a paraneoplastic syndrome; assigning SIADH before evaluating volume status and alternative causes can lead to inappropriate fluid or endocrine management.
Small Cell Lung Cancer Treatment (PDQ®)—Health Professional Version
42.Which findings suggest superior vena cava syndrome?
Superior vena cava obstruction impairs venous drainage from the head, neck, arms and upper chest. Facial or upper-extremity swelling, distended chest veins and dyspnea provide anatomical clues, particularly with an intrathoracic malignancy. Symptoms differ from isolated lower-body edema because the obstruction lies in upper-body venous return. Severity varies; airway or neurologic compromise increases urgency. Identifying the obstructing process is essential because treatment depends on the cause, anatomical burden and immediate physiological consequences.
Apply it
A patient with a thoracic mass develops facial puffiness, bilateral arm swelling and prominent upper-chest veins. Recognize impaired superior vena cava drainage and assess respiratory or neurologic compromise while arranging evaluation of the obstruction.
Common pitfall: Calling the swelling generalized fluid overload overlooks its upper-body distribution; the anatomical pattern can identify a central venous obstruction before systemic edema becomes prominent.
43.Which biochemical pattern should trigger urgent assessment for tumor lysis syndrome?
Rapid cancer-cell breakdown releases intracellular material into the circulation, particularly around treatment of susceptible leukemias and lymphomas. Hyperkalemia, hyperphosphatemia, hyperuricemia and secondary hypocalcemia form the characteristic metabolic pattern. Kidney injury can amplify these abnormalities by reducing clearance; arrhythmias and seizures are dangerous consequences. Recognize the pattern as an oncologic emergency requiring urgent electrolyte, cardiac and renal assessment. The mechanism and complications are described by [NCI](https://www.cancer.gov/publications/dictionaries/cancer-terms/def/tumor-lysis-syndrome) and [eviQ's tumor lysis guidance](https://www.eviq.org.au/clinical-resources/side-effect-and-toxicity-management/prophylaxis-and-treatment/108-prevention-of-tumour-lysis-syndrome).
Apply it
Soon after treatment for a bulky lymphoma, a patient develops rising potassium, phosphate, uric acid and creatinine with falling calcium. Escalate urgently for tumor lysis syndrome and its cardiac and renal complications rather than treating each laboratory abnormality as unrelated.
Common pitfall: Isolated hyperuricemia does not describe the whole emergency. Potassium, phosphate, calcium and renal function must be assessed together because immediate harm can arise from electrolyte disturbances as well as urate-related injury.
Internal Medicine Blueprint—Certification Examination (CERT)
44.Why does small cell lung cancer usually require systemic treatment?
Small cell lung cancer has a strong tendency toward early dissemination, so local treatment alone is insufficient for most patients. Limited-stage disease commonly receives combined systemic chemotherapy and thoracic radiotherapy, while extensive-stage disease relies principally on systemic treatment, often incorporating immunotherapy when appropriate. Surgery is reserved for selected very early presentations after careful staging. Stage, performance status and comorbidity determine the specific plan. The central principle is matching local and systemic treatment to a disease with substantial metastatic potential.
Apply it
A patient assumes a newly diagnosed small cell lung tumor should simply be surgically removed. Explain why complete staging and assessment for systemic therapy are necessary before choosing a local treatment approach for this tumor type.
Common pitfall: Applying the management assumptions of another lung cancer histology can overemphasize surgery; small cell biology makes systemic disease control central even when thoracic findings dominate.
Small Cell Lung Cancer Treatment (PDQ®)—Health Professional Version
Ophthalmology1%
45.When should a painful red eye raise concern for angle-closure glaucoma?
Acute angle closure obstructs aqueous humor drainage and can rapidly increase intraocular pressure, threatening vision. Severe eye pain, blurred vision, a red eye and nausea or vomiting are warning features requiring immediate ophthalmic evaluation. This presentation differs from uncomplicated conjunctivitis, in which severe pain and major visual disturbance are not expected defining features. Chronic open-angle glaucoma may be initially asymptomatic, so the urgent symptomatic syndrome should not be confused with routine glaucoma screening or follow-up.
Apply it
An adult develops sudden severe unilateral eye pain, blurred vision and vomiting with a red eye. Arrange immediate emergency ophthalmic assessment rather than prescribing routine conjunctivitis treatment and scheduling review several days later.
Common pitfall: Prominent nausea can distract attention toward a gastrointestinal diagnosis; accompanying eye pain and visual change identify a potentially vision-threatening ocular emergency needing prompt evaluation.
Otolaryngology and Dental Medicine1%
46.How do positional testing and repositioning address BPPV?
Benign paroxysmal positional vertigo results from displaced inner-ear particles that produce inappropriate vestibular stimulation with head movement. Brief position-triggered vertigo suggests the disorder; Dix–Hallpike testing that provokes torsional, upbeating nystagmus supports posterior-canal BPPV. Canalith repositioning treats the mechanical problem by moving particles out of the affected canal. Continuous symptoms, focal neurologic findings or an atypical examination require consideration of alternatives. Routine vestibular suppressant treatment does not correct the underlying particle displacement and should not replace appropriate repositioning.
Apply it
A patient experiences brief spinning when rolling over in bed, with characteristic positional nystagmus during Dix–Hallpike testing. Use a canalith repositioning maneuver instead of relying on continuing medication to suppress the recurrent mechanical trigger.
Common pitfall: Head movement can worsen many causes of dizziness; the brief triggered pattern and characteristic examination matter more than movement sensitivity alone when identifying BPPV.
BPPV: Experts Update Best Practices for Diagnosis and Treatment
Psychiatry4%
47.Which findings distinguish mania from hypomania?
Mania involves abnormally elevated or irritable mood with increased activity or energy and associated changes such as reduced sleep need, pressured speech, grandiosity and risky behavior. Marked functional impairment, hospitalization or psychotic features distinguish mania from hypomania. Manic episodes generally last at least one week, or any duration when hospitalization is necessary. Assessment must consider substances and medical causes. A person who sleeps little yet feels energized differs from someone distressed by insomnia and daytime exhaustion.
Apply it
A patient spends recklessly, sleeps two hours without fatigue and develops grandiose delusions requiring hospitalization. Recognize a manic episode rather than hypomania, while assessing safety, substance exposure and medical explanations for the behavioral change.
Common pitfall: Short symptom duration does not exclude mania when hospitalization is necessary, and psychotic features are incompatible with classifying the same episode as merely hypomanic.
48.When do panic attacks support a diagnosis of panic disorder?
A panic attack is an abrupt episode of intense fear or discomfort with physical and cognitive symptoms. Panic disorder requires recurrent unexpected attacks plus at least one month of persistent concern about additional attacks or maladaptive behavioral change. A single attack or attacks consistently explained by another disorder do not establish it. Medical and substance-related explanations must be considered. The diagnostic focus extends beyond dramatic symptoms during an episode to the continuing pattern and consequences between attacks.
Apply it
A patient has repeated unexpected episodes of palpitations and fear, then avoids leaving home for six weeks because another attack may occur. After appropriate evaluation, recognize the pattern supporting panic disorder rather than an isolated panic attack.
Common pitfall: Normal testing during one visit does not itself prove panic disorder; recurrent unexpected attacks and their persistent psychological or behavioral aftermath must establish the clinical pattern.
Pulmonary Disease9%
49.Which spirometric result supports COPD, and when should spirometry be repeated to confirm persistent obstruction?
FEV1 is the volume forcibly exhaled during the first second; FVC is the total volume exhaled during the forced maneuver. GOLD requires a post-bronchodilator FEV1/FVC below 0.70 for the airflow obstruction necessary to diagnose COPD in a compatible clinical setting. When the initial post-bronchodilator ratio is between 0.60 and 0.80, repeat spirometry on a separate occasion to confirm persistence because biological variation can change classification relative to the 0.70 threshold. Interpret spirometry alongside chronic respiratory symptoms and relevant exposures or other risk factors. Symptoms, smoking history and imaging alone cannot confirm the required obstruction.
Apply it
A patient with chronic cough, exertional dyspnea and substantial smoking exposure has a post-bronchodilator FEV1 of 1.8 L and FVC of 3.0 L. The ratio is 1.8 divided by 3.0, or 0.60. This is below GOLD's diagnostic cutoff but falls within the range requiring repeat testing. Repeat spirometry on a separate occasion before describing persistent obstruction as established. A repeat post-bronchodilator ratio below 0.70 confirms persistence and supports COPD in this compatible clinical setting.
Common pitfall: Post-bronchodilator obstruction on one occasion does not eliminate the need for confirmation when the ratio is 0.60–0.80. Repeating maneuvers during the same testing session does not substitute for testing on a separate occasion. Bronchodilator responsiveness can occur in both asthma and COPD, so a response alone neither excludes COPD nor establishes asthma. A low ratio also requires clinical interpretation rather than an automatic COPD diagnosis.
50.Who with COPD should be tested for alpha-1 antitrypsin deficiency?
All individuals with COPD should be tested for alpha-1 antitrypsin deficiency regardless of age or ethnicity. Early disease, limited smoking exposure, liver disease and family history heighten suspicion but are not prerequisites. Deficient alpha-1 antitrypsin permits protease-mediated lung injury. Serum concentration measures circulating protein but varies with inflammation and cannot fully distinguish genotypes. Diagnostic assessment includes genotyping at least the S and Z alleles, with confirmation through an independent method such as protein phenotype testing, level measurement or expanded genotyping as indicated.
Apply it
An older adult with substantial smoking exposure has newly confirmed COPD. Offer alpha-1 antitrypsin testing despite the apparently sufficient smoking explanation. If concentration and genotype findings disagree, pursue confirmatory assessment rather than accepting one result in isolation.
Common pitfall: Restricting testing to young nonsmokers misses the broader recommendation. A serum concentration alone does not fully characterize inherited risk or replace genotype or phenotype assessment.
Alpha-1 Antitrypsin Deficiency Clinical Practice Guidelines | Journal of the COPD Foundation
51.How should high clinical probability change pulmonary embolism testing?
Pulmonary embolism testing begins with clinical probability because the same test result has different meaning at different baseline risks. When probability is high, definitive imaging is generally required rather than using a D-dimer as a gatekeeper. CT pulmonary angiography is commonly used, with alternative pathways when contrast, radiation or clinical circumstances require them. Hemodynamic instability changes urgency and management. The key distinction is between a rule-out strategy for selected lower-risk patients and direct evaluation of a highly plausible embolism.
Apply it
A stable postoperative patient has sudden dyspnea, tachycardia and unilateral leg swelling, with high clinical probability of pulmonary embolism. Proceed to appropriate definitive imaging rather than ordering D-dimer to decide whether imaging is warranted.
Common pitfall: A rule-out test is useful only within its validated probability setting; using D-dimer to defer imaging in a high-probability presentation can provide false reassurance.
First AHA/ACC Acute Pulmonary Embolism Guideline: Prompt Diagnosis and Treatment Are Key
52.Why does a positive D-dimer not diagnose pulmonary embolism?
D-dimer reflects fibrin formation and breakdown rather than the anatomical presence of a pulmonary embolus. It can be elevated in many settings, so its principal diagnostic role is helping exclude embolism within an appropriate low- or intermediate-probability pathway. A positive result generally leads to further assessment rather than confirming the diagnosis. Clinical probability and the selected validated threshold determine interpretation. Avoid treating a nonspecific biochemical signal as equivalent to imaging evidence of pulmonary vascular obstruction.
Apply it
A stable patient with low clinical probability has a D-dimer above the applicable threshold. Follow the diagnostic pathway to appropriate imaging rather than telling the patient the blood test has already established pulmonary embolism.
Common pitfall: An elevated D-dimer increases the need for evaluation but does not identify the clot's location or prove embolism; nonspecific positivity must not become a diagnosis.
First AHA/ACC Acute Pulmonary Embolism Guideline: Prompt Diagnosis and Treatment Are Key
53.When should suspected obstructive sleep apnea be tested at home versus in a laboratory?
Technically adequate home sleep apnea testing is an option for uncomplicated adults at increased risk of moderate-to-severe obstructive sleep apnea. Prefer laboratory polysomnography for significant cardiorespiratory disease, suspected hypoventilation, respiratory muscle weakness, chronic opioid use, prior stroke or severe insomnia. A negative, inconclusive or technically inadequate home test should lead to polysomnography, rather than exclusion of OSA. Symptoms and questionnaires estimate risk but cannot independently establish the diagnosis. Laboratory testing provides broader physiological assessment when comorbidity or an unsuccessful home study limits interpretation.
Apply it
A patient with witnessed apneas and daytime sleepiness has a technically inadequate home test. Arrange polysomnography. If the same patient has significant heart failure or suspected hypoventilation, choose polysomnography at the outset.
Common pitfall: An unsuccessful or negative home study does not reliably exclude OSA. Repeating screening questionnaires cannot resolve inadequate physiological data or replace the recommended laboratory assessment.
Rheumatology and Orthopedics9%
54.Which synovial fluid finding confirms gout?
Gout results from deposition of monosodium urate crystals, which trigger intense joint inflammation. Identification of characteristic needle-shaped, negatively birefringent crystals in synovial fluid provides direct diagnostic evidence. Serum urate is useful in the broader assessment but can be misleading during an acute flare and does not itself prove that a painful joint contains urate crystals. Joint aspiration also permits evaluation for infection when appropriate, because a crystal-associated presentation does not automatically exclude a concurrent infectious process.
Apply it
A patient presents with a first acutely swollen knee and an elevated serum urate. Aspirate when indicated to examine crystals and assess infection instead of diagnosing gout from the serum measurement and joint pain alone.
Common pitfall: Hyperuricemia is a risk factor rather than proof of gout, and finding crystals does not eliminate concern for septic arthritis when the clinical circumstances suggest infection.
55.How do acute gout treatment and long-term urate lowering differ?
An acute gout flare is an inflammatory response to deposited crystals, so immediate treatment targets inflammation and pain. Long-term urate-lowering therapy reduces the urate burden that permits crystals to persist and future attacks to occur. These strategies answer different clinical needs and are not interchangeable. Recurrent attacks, tophi and other relevant disease features guide preventive treatment decisions. Lifestyle measures can help but may be insufficient alone when a substantial crystal burden or recurrent disease warrants pharmacologic prevention.
Apply it
A patient with repeated gout attacks asks whether taking an anti-inflammatory during each episode prevents further crystal accumulation. Explain the separate goals of flare control and sustained urate reduction when discussing long-term treatment options.
Common pitfall: Relief of an acute attack does not demonstrate removal of the underlying urate burden; an episodic anti-inflammatory strategy can leave recurrent disease mechanisms unchanged.
56.When does suspected giant cell arteritis require immediate treatment?
Giant cell arteritis can compromise blood flow to ocular structures and cause irreversible visual loss. New headache, jaw claudication and visual symptoms in an older adult warrant urgent assessment. When vision is threatened, the ACR/Vasculitis Foundation guideline conditionally favors pulse intravenous glucocorticoids over high-dose oral therapy alone. Diagnostic confirmation remains important, but treatment should not be delayed for temporal artery biopsy. The urgency arises from ischemic risk rather than the magnitude of an inflammatory-marker elevation.
Apply it
An older patient has a new temporal headache, jaw pain while chewing and transient monocular visual loss. Start urgent treatment for threatened vision while arranging confirmatory assessment rather than waiting several days for biopsy availability.
Common pitfall: A planned biopsy does not justify withholding treatment from a patient with threatened vision; preventing irreversible ischemic injury takes priority over obtaining an untreated tissue sample.
57.Which joint pattern suggests rheumatoid arthritis?
Rheumatoid arthritis is an autoimmune inflammatory disease in which synovitis can damage joints and affect other organs. Symmetric swelling and pain in small hand or foot joints, accompanied by prolonged morning stiffness, suggest an inflammatory pattern. Symptoms improving after movement differ from purely use-related discomfort. No single symptom or blood test independently establishes the diagnosis. Examination for objective synovitis, disease duration and relevant laboratory or imaging findings together distinguish rheumatoid arthritis from mechanical pain and other inflammatory arthritides.
Apply it
A patient has bilateral swollen finger joints and morning stiffness that improves after an hour of activity. Evaluate for inflammatory synovitis rather than attributing the symptoms to keyboard use based only on the patient's occupation.
Common pitfall: Joint pain alone is not synonymous with rheumatoid arthritis; the distribution, swelling and inflammatory time pattern are more discriminating than pain severity or an isolated antibody result.
58.Why does rheumatoid arthritis require disease-modifying treatment?
Persistent immune-mediated synovitis can produce structural joint damage even when pain is temporarily controlled. Disease-modifying antirheumatic drugs target the underlying inflammatory process and are central to preventing progression. Analgesics and anti-inflammatory drugs may improve symptoms but do not provide equivalent protection against damage. Early treatment and monitoring of disease activity support better outcomes. Medication selection must also account for comorbidity and toxicity, so therapeutic success includes suppression of inflammation and preservation of function rather than comfort alone.
Apply it
A patient with newly diagnosed rheumatoid arthritis reports good pain relief from an anti-inflammatory and asks to postpone disease-modifying therapy indefinitely. Explain that symptom relief does not reliably prevent ongoing inflammatory joint damage.
Common pitfall: Using pain relief as the sole treatment target can miss persistent synovitis; a comfortable patient may still require disease-modifying adjustment to protect joint structure and function.
Geriatric Syndromes3%
59.How does delirium differ from a chronic cognitive disorder?
Delirium is an acute disturbance of attention and awareness that often fluctuates over hours or days. It may be hyperactive, hypoactive or mixed, so quiet withdrawal can be as important as agitation. A chronic cognitive disorder usually develops more gradually, although delirium can occur on top of pre-existing dementia. Establishing the patient's baseline and timing of change is essential. Acute inattention should prompt a search for medical, medication-related and environmental contributors rather than being attributed automatically to aging.
Apply it
A normally conversational older patient becomes intermittently inattentive and unusually quiet after hospitalization. Ask family about baseline function and investigate an acute delirium even though the patient is not agitated or attempting to leave bed.
Common pitfall: Hypoactive delirium can resemble fatigue or depression; absence of disruptive behavior does not make an acute fluctuating change in attention benign or purely chronic.
60.Which supportive measures help a patient with delirium?
Delirium management begins with identifying and treating precipitating causes while reducing disorientation and physiological stress. Reassurance, familiar people, clear communication, clocks, daylight exposure and an appropriate sleep environment can support recovery. Hearing aids and glasses help patients interpret their surroundings. Medication review, hydration, pain assessment and safe mobility address potentially reversible contributors. Supportive care should be individualized to the patient rather than equating treatment with sedation, because suppressing visible agitation does not correct the underlying disturbance.
Apply it
An older inpatient with delirium cannot hear staff clearly and sleeps throughout the day. Restore hearing aids, improve orientation and sleep cues, review medications and investigate triggers while maintaining safe supervision during recovery.
Common pitfall: Sedating every confused patient can obscure assessment and worsen function; environmental support and correction of precipitating factors remain central even when agitation requires additional management.
What to focus on during revision
The following are CertMedbry study suggestions. Use the official outline to check the full scope of your examination.
- Use the complete January 2026 certification blueprint to track omitted topics; the 60 concepts are selected teaching priorities, not the full curriculum.
- Give Cardiovascular Disease the largest study share, then distribute substantial practice across the five 9% domains.
- Study hypertension across cardiovascular, renal and endocrine settings; its cross-listed 5% allocation is already included in the official total.
- Practise probability-based testing: distinguish screening, confirmation, exclusion, localization and assessment of severity.
- Prioritize time-sensitive decisions involving anaphylaxis, adrenal crisis, threatened vision, suspected pulmonary embolism and acute ocular pain.
- Connect laboratory results to physiology: ACTH with cortisol, PTH with calcium, urine concentration with serum sodium, and albuminuria with eGFR.
- Include prevention, infection control, clinical epidemiology, patient safety and health equity within organ-system study, as the blueprint permits these themes across categories.
A practical preparation plan
1. Map the full certification scope
Create a study tracker from all 18 official domains and their detailed topics. Mark these 60 concepts as selected coverage, then schedule additional work on unrepresented topics such as dysrhythmias, pancreatic disease, hemolytic anemia and systemic lupus erythematosus.
2. Build decision pairs
For each topic, compare two plausible alternatives and identify the finding that changes management: primary versus central adrenal insufficiency, colonization versus urinary infection, low-probability versus high-probability embolism testing, or symptomatic relief versus disease modification.
3. Work the questions before reading explanations
Answer the 20 independent questions and record both your selected option text and decisive clinical cue. Review every alternative, including those you rejected correctly, to detect incomplete reasoning rather than counting correct answers alone.
4. Rehearse calculations and conditional thresholds
Calculate NNT and serum–ascites albumin gradients without looking at examples. Rehearse ascitic neutrophil thresholds, CKD chronicity and severe high-gradient aortic stenosis criteria together with their limitations and relevant clinical context.
5. Use spaced recall to strengthen weak decisions
Review the flashcards at increasing intervals and explain each answer aloud. Return missed decisions to their primary references, then create a new clinical variation that changes one important feature, such as pregnancy, immune status or symptom severity.
6. Reassess clinical reasoning and remaining scope
For each missed decision, identify whether the error concerned disease recognition, mechanism, test interpretation or treatment selection. Revisit the complete official outline to identify additional topics requiring study. Performance on this small learning set does not establish a passing-score estimate.
Use your sample score as a starting point
The free set contains 20 original practice questions. It is a small learning sample, not an official examination or a validated pass prediction. Review each explanation and its source before moving to another topic.
Start the free sampleOfficial sources and updates
- Internal Medicine & Subspecialty Policies
- Blueprints
- Internal Medicine Blueprint—Certification Examination (CERT)
- Expanded Blueprints
- 2020 ACC/AHA Heart Valve Disease Guideline: Key Perspectives, Part 3
- 2022 AHA/ACC/HFSA Heart Failure Guideline: Key Perspectives
- 2020 ACC/AHA Heart Valve Disease Guideline: Key Perspectives, Part 1
- Primary Adrenal Insufficiency Guideline Resources
- Graves’ Disease
- Celiac Disease Tests
- Why Timing Matters: Paracentesis on Admission for Cirrhosis with Ascites
- IDSA 2019 Clinical Practice Guideline Update for the Management of Asymptomatic Bacteriuria
- Clinical and Laboratory Diagnosis for Tuberculosis
- COPD—Diagnosis
- First AHA/ACC Acute Pulmonary Embolism Guideline: Prompt Diagnosis and Treatment Are Key
- Gout: Diagnosis, Treatment, and Steps to Take
- 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis
- Anemia—Iron-Deficiency Anemia
- Diagnosis of Urinary Retention
- Parkinson’s Disease
- Small Cell Lung Cancer Treatment (PDQ®)—Health Professional Version
- Bipolar Disorder
- Delirium
- Anaphylaxis: A 2023 Practice Parameter Update
- A Focused Parameter Update: Hereditary Angioedema, Acquired C1 Inhibitor Deficiency, and ACE Inhibitor–Associated Angioedema
- Psoriasis
- Primary Hyperparathyroidism
- Anemia—Vitamin B12–Deficiency Anemia
- Appendix A: Type and Duration of Precautions Recommended for Selected Infections and Conditions
- Chapter 15: Interpreting Results and Drawing Conclusions
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
- Myasthenia Gravis
- Appendix A: Summary of Classifications for U.S. Medical Eligibility Criteria for Contraceptive Use, 2024
- NCI Dictionary of Cancer Terms: Superior Vena Cava Syndrome
- Glaucoma
- BPPV: Experts Update Best Practices for Diagnosis and Treatment
- Panic Disorder: What You Need to Know
- Sleep Apnea—Diagnosis
- Rheumatoid Arthritis
- Cushing’s Syndrome
- Thyroiditis | American Thyroid Association
- Guideline-2021-AASLD-ascites-2021.pdf
- Parkinson's Disease | PD | MedlinePlus
- GOLD-REPORT-2026-v1.2-20Nov2025_WMV.pdf
- Alpha-1 Antitrypsin Deficiency Clinical Practice Guidelines | Journal of the COPD Foundation
- diagnostic-testing-osa.pdf
- KDIGO-2012-AKI-Guideline-English.pdf
- Diabetes Tests & Diagnosis - NIDDK
- Psoriatic Arthritis Symptoms, Causes, & Risk Factors | NIAMS
- Symptoms & Causes of GI Bleeding - NIDDK
- Treatment for GI Bleeding - NIDDK
- ash_vte_hit_pocketguide.pdf
- 108-Prevention of tumour lysis syndrome | eviQ
- diagnostic-testing-osa.pdf
- Rheumatoid Arthritis: Diagnosis, Treatment, and Steps to Take
Confirm current eligibility, fees, scheduling and policies directly with the examination provider. CertMedbry is independent and is not endorsed by these organisations. How we handle content and corrections.